
NASDAQHealthcareMedical - Instruments & Supplies
أحدث البيانات المتاحة
8.24 US$
+0.11 US$ · +1.35%
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through websites and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic laboratories. It primarily sells its products under the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS, Warner, DSI, Panlab, Hugo Sachs, and Buxco brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.
الإغلاق السابق
8.24 US$
+0.11 US$ · +1.35%
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through websites and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic laboratories. It primarily sells its products under the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS, Warner, DSI, Panlab, Hugo Sachs, and Buxco brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.
نطاق اليوم
السعر الحالي 8.24 US$
نطاق 52 أسبوعًا
السعر الحالي 8.24 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
بيع
تقييم
46
قيمة عادلة
المشاعر
51
مختلط
المخاطر
67
مخاطر مرتفعة
الزخم
44
محايد
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through websites and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic laboratories. It primarily sells its products under the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS, Warner, DSI, Panlab, Hugo Sachs, and Buxco brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.
نطاق اليوم
السعر الحالي 8.24 US$
نطاق 52 أسبوعًا
السعر الحالي 8.24 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 | السنة المالية 2021 |
|---|---|---|---|---|---|
| الإيرادات | 86.55 مليون USD | 94.14 مليون USD | 112.25 مليون USD | 113.34 مليون USD | 118.9 مليون USD |
| تكلفة البضاعة المباعة | 40.67 مليون USD | 39.37 مليون USD | 46.18 مليون USD | 52.52 مليون USD | 51.25 مليون USD |
| الربح الإجمالي | 45.88 مليون USD | 54.77 مليون USD | 66.07 مليون USD | 60.82 مليون USD | 67.65 مليون USD |
| البحث والتطوير | 8.83 مليون USD | 10.41 مليون USD | 11.76 مليون USD | 12.33 مليون USD | 10.8 مليون USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 36.96 مليون USD | 43.71 مليون USD | 46.89 مليون USD | 49.53 مليون USD | 48.95 مليون USD |
| نفقات التشغيل | 46.51 مليون USD | 60.98 مليون USD | 64.18 مليون USD | 67.75 مليون USD | 65.59 مليون USD |
| مصاريف الفوائد | 4.92 مليون USD | 3.21 مليون USD | 3.59 مليون USD | 2.55 مليون USD | 1.54 مليون USD |
| الاستهلاك والإطفاء | 5.95 مليون USD | 7.16 مليون USD | 7 مليون USD | 7.58 مليون USD | 7.62 مليون USD |
| الدخل التشغيلي | −629 ألف USD | −6.21 مليون USD | 1.89 مليون USD | −6.93 مليون USD | 2.07 مليون USD |
| صافي الدخل | −56.7 مليون USD | −12.41 مليون USD | −3.42 مليون USD | −9.52 مليون USD | −288 ألف USD |
تم تحديث حقائق الشركة 12 أكتوبر 2026.
صناديق متداولة تفصح عن تعرضها لهذا السهم.
Vanguard Morningstar Total Stock Market ETFVTI1 مليون0.00%2.3 ترليون USD0.03%381.94 US$+0.63%
Vanguard Extended Market ETFVXF340.97 ألف0.00%95.4 مليار USD0.05%235 US$+0.80%
Dimensional - US Sustainability Core 1 ETFDFSU15.46 ألف0.00%2.39 مليار USD0.15%48.11 US$+0.48%
Dimensional - US Small Cap ETFDFAS13.2 ألف0.00%33.87 مليار USD0.31%78.35 US$+0.32%
U.S. Vector Equity Portfolio ETF Class SharesDXUV9.99 ألف0.00%6.18 مليار USD0.26%68.28 US$+0.25%
Dimensional - US Core Equity 2 ETFDFAC8.37 ألف0.00%88.6 مليار USD0.21%45.33 US$+0.49%
U.S. Core Equity 1 Portfolio ETF Class SharesDCOR7.54 ألف0.00%45.59 مليار USD0.17%84.44 US$+0.44%
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Extended Market ETFVXF
Dimensional - US Sustainability Core 1 ETFDFSU
Dimensional - US Small Cap ETFDFAS
U.S. Vector Equity Portfolio ETF Class SharesDXUV
Dimensional - US Core Equity 2 ETFDFAC
U.S. Core Equity 1 Portfolio ETF Class SharesDCORالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.